EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study

Claudia Riccardi iD, Antonella Campanella, Daniela Montesarchio iD, Pompea Del Vecchio iD, Rosario Oliva iD, Luigi Paduano

Molecules · 2023

DOI: 10.3390/molecules28062800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Claudia Riccardi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, University Federico II of Napoli, Via Cintia 21, 80126 Napoli, Italy. Hauptthemen laut MEDLINE: Ruthenium, Coordination Complexes, Antineoplastic Agents, Organometallic Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC (Associazione Italiana per la Ricerca sul Cancro).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ruthenium(III) complexes are very promising candidates as metal-based anticancer drugs, and several studies have supported the likely role of human serum proteins in the transport and selective delivery of Ru(III)-based compounds to tumor cells. Herein, the anticancer nanosystem composed of an amphiphilic nucleolipid incorporating a Ru(III) complex, which we named DoHuRu, embedded into the biocompatible cationic lipid DOTAP, was investigated as to its interaction with two human serum proteins thought to be involved in the mechanism of action of Ru(III)-based anticancer drugs, i.e., human serum albumin (HSA) and human transferrin (hTf). This nanosystem was studied in comparison with the simple Ru(III) complex named AziRu, a low molecular weight metal complex previously designed as an analogue of NAMI-A, decorated with the same ruthenium ligands as DoHuRu but devoid of the nucleolipid scaffold and not inserted in liposomal formulations. For this study, different spectroscopic techniques, i.e., Fluorescence Spectroscopy and Circular Dichroism (CD), were exploited, showing that DoHuRu/DOTAP liposomes can interact with both serum proteins without affecting their secondary structures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RutheniumCoordination ComplexesAntineoplastic AgentsOrganometallic CompoundsHumansBlood ProteinsLiposomesQuaternary Ammonium CompoundsFatty Acids, Monounsaturated

Stichwörter der Autor:innen

anticancer drugsinteractionsliposomesruthenium(III) complexesserum proteins

Substanzen

RutheniumCoordination ComplexesAntineoplastic AgentsBlood ProteinsLiposomesOrganometallic Compounds1,2-dioleoyloxy-3-(trimethylammonium)propaneQuaternary Ammonium CompoundsFatty Acids, Monounsaturated

Autor:innen und Institutionen

  • Department of Chemical Sciences, University Federico II of Napoli, Via Cintia 21, 80126 Napoli, Italy.
  • CINMPIS-Consorzio Interuniversitario Nazionale di Ricerca in Metodologie e Processi Innovativi di Sintesi, Via E. Orabona 4, 70125 Bari, Italy.
  • CSGI-Consorzio Interuniversitario per Lo Sviluppo dei Sistemi a Grande Interfase, Via della Lastruccia 3, 50019 Florence, Italy.

ORCID-Profile: Claudia Riccardi, Daniela Montesarchio, Pompea Del Vecchio, Rosario Oliva

Förderung

  • AIRC (Associazione Italiana per la Ricerca sul Cancro)

Zitieren

APA

Riccardi, C., Campanella, A., Montesarchio, D., Del Vecchio, P., Oliva, R., & Paduano, L. (2023). Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study. Molecules. https://doi.org/10.3390/molecules28062800

Vancouver

Riccardi C, Campanella A, Montesarchio D, Del Vecchio P, Oliva R, Paduano L. Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study. Molecules. 2023. doi:10.3390/molecules28062800

BibTeX
@article{Riccardi2023,
  author = {Riccardi, Claudia and Campanella, Antonella and Montesarchio, Daniela and Del Vecchio, Pompea and Oliva, Rosario and Paduano, Luigi},
  title = {Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28062800}
}
Kostenlos starten →